SCHEMBL8360489

SCHEMBL8360489

C/C=C(\C)CC(=O)Nc1ccc2c(c1)cc(C(=O)Nc1ccccc1)n2Cc1ccccc1F

nearest known ligand 0.75

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ECE1 P42892 20/20 0.75

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8362937 0.95 ECE1 (0.68) ECE1
SCHEMBL8360499 0.91 ECE1 (0.63) ECE1
SCHEMBL8338254 0.88 ECE1 (0.78) ECE1
SCHEMBL8362933 0.88 ECE1 (0.64) ECE1
SCHEMBL8360498 0.87 ECE1 (0.65) ECE1
SCHEMBL8361133 0.86 ECE1 (0.60) ECE1
SCHEMBL8363682 0.86 ECE1 (0.64) ECE1
SCHEMBL8334888 0.86 ECE1 (0.64) ECE1
SCHEMBL6020370 0.86 ECE1 (1.00) ECE1
SCHEMBL8363706 0.86 ECE1 (0.79) ECE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003028719-A1 SUBSTITUTED 2,5-DIAMIDOINDOLES AS ECE INHIBITORS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES BAYER HEALTHCARE AG (DE) 2003-04-10 WO disclosed